Home » Topics » BioWorld Science

BioWorld Science
RSS

GSK-2256098/trametinib combination lacks activity in phase II PDAC study

Jan. 30, 2018

United Neuroscience to develop vaccine to prevent chronic traumatic encephalopathy

Jan. 30, 2018

EMA committee recommends approval of Lamzede for alpha-mannosidosis

Jan. 30, 2018

ASPH marker possibly useful for CRC screening

Jan. 30, 2018

Trial results support safety and activity of carotuximab + sorafenib in hepatocellular carcinoma

Jan. 30, 2018

Zika virus vaccine candidate from Takeda obtains FDA fast track designation

Jan. 30, 2018

FDA gives fast track status to Ensysce's PF-614

Jan. 30, 2018

Sun Biopharma initiates first-line combination study of SBP-101 with gemcitabine and nab-paclitaxel

Jan. 30, 2018

Patient enrollment ongoing in first-in-human trial of PF-06939926

Jan. 30, 2018

American Gene Technologies makes progress towards phase I study of HIV functional cure product

Jan. 29, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...